Zosano Pharma Corp to host Call to Provide a Corporate Update and Share Plans for Commercialization Readiness for QtryptaT
Llamada en conferencia Zosano Pharma Corp
Zosano Pharma Corp Conference call will be held on 26-mar-2020. During the earnings conference call's session Zosano Pharma Corp will provide updated information and financial status.
Conference call is also referred to as: teleconference call or audio conference bridge. Conferencing service is provided in house or as cloud based teleconference service.
In order to join the audio conferencing dial conference bridge and key in the PIN code, Contact Zosano Pharma Corp for this information
Schedule an online conference with QCONF conference service and get 5 free calls with online conferencing.
Zosano Pharma Corporation and its subsidiary ("Company") is a clinical stage pharmaceutical company that has developed a proprietary intracutaneous delivery system. It can offer rapid absorption of drug, consistent drug delivery, improved ease of use and room-temperature stability, benefits that we believe differentiate our delivery platform from other non-oral formulations or injections. By focusing our development efforts on the delivery of established molecules with known safety and efficacy and premium pricing, we plan to reduce our clinical and regulatory risk and development costs and accelerate our time to commercialization. Our intracutaneous patch consists of an array of titanium microneedles that is coated with our proprietary formulation of a previously approved drug that is attached to an adhesive patch.Leer más Llamada en conferencia